| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.044 | 0.1 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.1 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.21 | 0.1 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |